Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Quest Diagnostics Downgraded to Neutral at Citi

Published 04/04/2022, 04:14 PM
Updated 04/04/2022, 04:18 PM
© Reuters.

By Sam Boughedda

Investing.com -- Quest Diagnostics Incorporated (NYSE:DGX) closed 1.3% lower Monday after Citi analyst Ralph Giacobbe downgraded the stock to neutral from buy.

The analyst pointed to several reasons for the downgrade. 

"We are downgrading DGX to Neutral due primarily to concerns around the margin outlook in 2022 and 2023 on the heels of higher internal investments, heightened labor pressures, and potential for reimbursement cuts as the COVID PHE (Public Health Emergency) gradually rolls off along with concurrent volume declines," Giacobbe said in a note to clients. 

He added that the firm "believe it will take more than a year for the internal investments in Advanced Diagnostics and the buildout of the direct-to-consumer (DTC) platform to increase base business sales meaningfully as DGX transitions to a COVID-endemic world."

Giacobbe set a price target of $175, up from $140 on the shares, which closed Monday's session at $134.54.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.